Peri, R
[4] Wegovy is administered as a once-weekly subcutaneous injection, with dosing gradually increased over 16-20 weeks (starting at 0.25 mg and increasing monthly to 0.5 mg, 1.0 mg, 1.7 mg, and finally 2.4 mg) to minimise gastrointestinal side effects
Patients should also be aware that the duration of Ozempic use can vary based on individual health needs and responsiveness to the medication
For patients under 21, MassHealth will still cover GLP-1s if theres medical necessity, but that qualification concerns pediatricians
Practical recommendations: If desired for comfort, remove the pen from the refrigerator 1530 minutes before your scheduled injection time Allow it to reach room temperature naturallynever use external heat sources Do not use a microwave, hot water, or direct sunlight to warm the pen The pen should feel neutral to touch, not cold Some patients find that even with room-temperature injection, they experience mild discomfort
Many patients stay on a therapeutic plan for several months, transitioning to a maintenance phase once goals are achieved